GLOBAL CLINICO-EPIDEMIOLOGIC CHARACTERISTICS OF OCULAR CANCER AND ITS IMPLICATIONS FOR GLOBAL HEALTH POLICY: A NARRATIVE REVIEW

Authors

U.A. Eze1,2, A.A. Salami1,3,4, K. Aminu1, C. Norah1, T. Akinyemiju1, A.A. Gbadamosi1,
C. Olomo1, E.B. Okeke1, K.K. Kanmodi1,5,6, H.A. Alen7

Correspondents

Dr. A.A. Salami
Department of Oral and
Maxillofacial Surgery,
University College Hospital,
Ibadan.
Email: afeezsalami2016@gmail.com

Affiliation of Authors

1. Cephas Health Research Initiative Inc, Ibadan, Nigeria.
2. Department of Ophthalmology, Federal Medical Center, Asaba, Nigeria.
3. School of Nursing, Midwifery and Public Health, University of Suffolk, Ipswich, United Kingdom.
4. Department of Oral and Maxillofacial Surgery, University College Hospital, Ibadan.
5. Department of Public Health, Thomas Adewumi University, Oke-Irese, Nigeria.
6. Department of Community Dentistry, United of Witwatersrand, Johannesburg, South Africa.
7. Department of Ophthalmology, University College Hospital, Ibadan, Nigeria.

ABSTRACT

Introduction: Ocular cancer refers to a group of rare but serious malignancies that affect the eye and its surrounding structures. Although ocular cancers account for less than 0.1% of all cancers globally, they represent a significant public health challenge because of their impact on vision, quality of life, and overall patient’s survival. The most common forms are retinoblastoma in
children and uveal melanoma in adults. Improving global outcomes requires integrating ocular cancer control into broader health policies, expanding research, and specialist care capacity. Stronger collaboration and equitable access to eye cancer care can reduce disparities and improve survival.

Objective: This narrative review underlines the global epidemiology of ocular cancer and discusses its implications for global health policy.

Methods: This narrative review utilized secondary data sources obtained through a thorough literature search of relevant articles on multiple electronic databases including PubMed, Google Scholar, and Web of Science. All published books, journal articles, and other published materials that were written in English were reviewed for the purpose of this study.

Results: The global burden of ocular cancer is rising, influenced by longer life expectancy, increased ultraviolet radiation exposure, genetic mutations, and unequal access to healthcare services. Key risk factors include inherited mutations such as RB1, BAP1, and TP53, viral infections like HPV and Epstein Barr virus, immunosuppression, fair skin pigmentation, and environmental
conditions. Preventive measures include the use of UV-protective eyewear, early screening, public health education, and genetic counselling. Diagnosis relies on advanced imaging, histopathology, and molecular testing to guide personalized treatment. Management typically requires a multidisciplinary team involving ophthalmologists, oncologists, pathologists, and radiologists. The treatment includes surgery, chemo-radiation therapy, targeted therapy, and immunotherapy. Importantly, the role of research in limiting burden and improving care cannot be overemphasized.

Conclusion: Although ocular cancers are rare, they are associated with significant morbidity. Therefore, modern diagnostics and therapeutic techniques are hugely required for better treatment outcome.

Keywords: Ocular cancer; Prevention; Diagnosis; Treatment; Prognosis; Global health policy.

Scroll to Top